Viridian Therapeutics, Inc.
VRDN· Nasdaq
VRDNViridian Therapeutics, Inc.
Filed Mar 21, 2016 · 10-K · 81 days after period end · 0001171843-16-008702
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|
| Revenue | $1.60M | $1.51M | — |
| Net Income | -$2.98M | -$2.26M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Viridian Therapeutics, Inc. · CIK 1590750 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 21, 2016 · 81 d after period end
